BITRF (Biotron) Long-Term Capital Lease Obligation : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Biotron Long-Term Capital Lease Obligation?

Biotron's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil.

Biotron's quarterly Long-Term Capital Lease Obligation increased from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($0.01 Mil) but then declined from Jun. 2023 ($0.01 Mil) to Dec. 2023 ($0.00 Mil).

Biotron's annual Long-Term Capital Lease Obligation declined from Jun. 2022 ($0.03 Mil) to Jun. 2023 ($0.01 Mil) and declined from Jun. 2023 ($0.01 Mil) to Jun. 2024 ($0.00 Mil).

Biotron Long-Term Capital Lease Obligation Historical Data

The historical data trend for Biotron's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotron Long-Term Capital Lease Obligation Chart

Biotron Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.03

0.01

Biotron Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.03	-	0.01	-	-

Biotron (OTCPK:BITRF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Biotron Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Biotron's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (OTCPK:BITRF) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

BIT:Australia

Address

56 Delhi Road, Suite 3.3, North Ryde, Sydney, NSW, AUS, 2113

Website

https://www.biotron.com.au

Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Biotron Headlines

From GuruFocus

Biotron Drug Effective Against COVID-19 In Animals

By PRNewswire PRNewswire • 11-25-2021